Ceftaroline
Sponsors
Forest Laboratories, Pfizer, Gary E. Stein, Pharm.D., Keith A. Rodvold, Henry Ford Health System
Conditions
Acute Bacterial Skin and Skin Structure InfectionsBacteremiaBacterial InfectionBacterial InfectionsCerebrospinal Fluid ShuntsCirculatory System
PaediatricsCommunity-Acquired Bacterial PneumoniaCommunity-acquired
Phase 1
Pharmacokinetics of Ceftaroline in Subjects 12 to 17 Years of Age
CompletedNCT00633126
Start: 2008-03-31End: 2009-02-28Updated: 2017-03-14
A Single-centre, Randomised, Double-blind, Placebo-controlled, Four Way Crossover Phase I Study to Investigate the Effect on QT/QTc Interval of Ceftazidime NXL104 or Ceftaroline Fosamil NXL104, Compared With Placebo, Using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male Volunteers
CompletedNCT01290900
Start: 2011-02-28End: 2011-05-31Updated: 2017-09-01
Ceftaroline China Pharmacokinetics Study
CompletedNCT01458743
Start: 2011-10-31End: 2012-04-30Updated: 2017-09-05
Pharmacokinetics of Ceftaroline in Normal and Obese Subjects
CompletedNCT01648127
Start: 2012-07-31End: 2013-02-28Updated: 2013-03-14
Ceftaroline Diffusion Into Cerebrospinal Fluid of Children
NCT02600793
Start: 2016-08-31End: 2019-12-31Target: 12Updated: 2018-10-04
Population Pharmacokinetic (PK) Study of Zinforo (Ceftaroline) in Critical Care Patients With Early-onset Pneumonia and Normal or Augmented Renal Clearance
CompletedNCT03025841
Start: 2016-12-31End: 2018-06-30Updated: 2019-03-11
Phase 2
Phase 3
Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
CompletedNCT00423657
Start: 2007-03-31End: 2007-12-31Updated: 2017-03-14
Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
CompletedNCT00424190
Start: 2007-02-28End: 2007-11-30Updated: 2017-03-14
A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia
CompletedNCT01371838
Start: 2011-12-31End: 2013-05-31Updated: 2017-09-06
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
RecruitingNCT02735707
Start: 2016-04-11End: 2028-02-29Target: 20000Updated: 2024-07-12
Phase 4
Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia
CompletedNCT01524302
Start: 2012-02-29End: 2015-04-30Updated: 2016-04-12
Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients
TerminatedNCT01734694
Start: 2011-10-31End: 2012-09-30Updated: 2023-05-03
Ceftaroline in the Treatment of Bone and Joint Infections
WithdrawnNCT02005068
Start: 2013-04-30End: 2014-07-31Updated: 2014-08-07
The Use of Ceftaroline as Surgical Prophylaxis in Surgery With Risk of MRSA Infection
NCT02307006
Start: 2015-01-31End: 2017-06-30Target: 500Updated: 2015-12-02
Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA
CompletedNCT02582203
Start: 2012-02-29End: 2016-05-31Updated: 2016-11-01
IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB
CompletedNCT02660346
Start: 2015-11-30End: 2018-01-30Updated: 2018-02-01
Antibiotic Prophylaxis in Open Fractures
NCT02937181
Start: 2016-12-31End: 2019-03-31Target: 50Updated: 2016-10-28
Pharmacokinetic and Pharmacodynamic Analysis of Ceftaroline in Children and Adolescents With Cystic Fibrosis
CompletedNCT03771313
Start: 2017-09-01End: 2025-07-31Updated: 2025-09-05
Unknown Phase
Related Papers
24 more papers not shown